Loss of heterozygosity predicts poor survival after resection of pancreatic adenocarcinoma

Journal of Gastrointestinal Surgery

Volumn 12, Issue 10, 2008, Pages 1664-1673

  Franko, Jan ^a   Krasinskas, Alyssa M ^b   Nikiforova, Marina N ^b   Zarnescu, Narcis O ^a   Lee, Kenneth K W ^a   Hughes, Steven J ^a   Bartlett, David L ^a   Zeh III, Herbert J ^a   Moser, A James ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

KRAS; Loss of heterozygosity; Pancreatic adenocarcinoma; Surgical resection

Indexed keywords

EID: 52649085279     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-008-0577-9     Document Type: Conference Paper

References (60)

1. SF Sener A Fremgen HR Menck DP Winchester 1999 Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database J Am Coll Surg 189 1 7
2. KY Bilimoria DJ Bentrem CY Ko AK Stewart DP Winchester MS Talamonti 2007 National failure to operate on early stage pancreatic cancer Ann Surg 246 173 180
3. C Fernandez-del Castillo J Targarona SP Thayer DW Rattner WR Brugge AL Warshaw 2003 Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients Arch Surg 138 427 423 discussion 33-4
4. JL Cameron TS Riall J Coleman KA Belcher 2006 One thousand consecutive pancreaticoduodenectomies Ann Surg 244 10 15
5. MA Makary JM Winter JL Cameron KA Campbell D Chang SC Cunningham 2006 Pancreaticoduodenectomy in the very elderly J Gastrointest Surg 10 347 356
6. SM de Castro KF Kuhlmann NT van Heek OR Busch GJ Offerhaus TM van Gulik 2004 Recurrent disease after microscopically radical (R0) resection of periampullary adenocarcinoma in patients without adjuvant therapy J Gastrointest Surg 8 775 784 discussion 84
7. C Sperti C Pasquali A Piccoli S Pedrazzoli 1997 Recurrence after resection for ductal adenocarcinoma of the pancreas World J Surg 21 195 200
8. CR Ferrone MF Brennan M Gonen DG Coit Y Fong S Chung 2008 Pancreatic adenocarcinoma: the actual 5-year survivors J Gastrointest Surg 12 701 706
9. CJ Yeo JL Cameron KD Lillemoe TA Sohn KA Campbell PK Sauter 2002 Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality Ann Surg 236 355 366 discussion 66-8
10. JG Fortner 1973 Regional resection of cancer of the pancreas: a new surgical approach Surgery 73 307 320
11. JG Fortner DS Klimstra RT Senie BJ Maclean 1996 Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy Ann Surg 223 147 153
12. Greene F, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, et al, editors. AJCC Cancer Staging Manual. 6 ed: Springer; 2002.
13. MF Brennan MW Kattan D Klimstra K Conlon 2004 Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas Ann Surg 240 293 298
14. TM Pawlik AL Gleisner JL Cameron JM Winter L Assumpcao KD Lillemoe 2007 Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer Surgery 141 610 618
15. KY Bilimoria DJ Bentrem CY Ko J Ritchey AK Stewart DP Winchester 2007 Validation of the 6(th) edition AJCC pancreatic cancer staging system: report from the National Cancer Database Cancer 110 738 744
16. CR Ferrone MW Kattan JS Tomlinson SP Thayer MF Brennan AL Warshaw 2005 Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival J Clin Oncol 23 7529 7535
17. S Paik S Shak G Tang C Kim J Baker M Cronin 2004 A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med 351 2817 2826
18. LA Habel S Shak MK Jacobs A Capra C Alexander M Pho 2006 A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients Breast Cancer Res 8 R25
19. LV Sequist DW Bell TJ Lynch DA Haber 2007 Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer J Clin Oncol 25 587 595
20. L Mina SE Soule S Badve FL Baehner J Baker M Cronin 2007 Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue Breast Cancer Res Treat 103 197 208
21. L Marchionni RF Wilson AC Wolff S Marinopoulos G Parmigiani EB Bass 2008 Systematic review: gene expression profiling assays in early-stage breast cancer Ann Intern Med 148 358 369
22. T Watanabe TT Wu PJ Catalano T Ueki R Satriano DG Haller 2001 Molecular predictors of survival after adjuvant chemotherapy for colon cancer N Engl J Med 344 1196 1206
23. K Kojima SM Vickers NV Adsay NC Jhala HG Kim TR Schoeb 2007 Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia Cancer Res. 67 8121 8130
24. C Almoguera D Shibata K Forrester J Martin N Arnheim M Perucho 1988 Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes Cell 53 549 554
25. YK Fung AL Murphree A T'Ang J Qian SH Hinrichs WF Benedict 1987 Structural evidence for the authenticity of the human retinoblastoma gene Science. 236 1657 1661
26. RH Hruban M Goggins J Parsons SE Kern 2000 Progression model for pancreatic cancer Clin Cancer Res 6 2969 2972
27. SE Kern RH Hruban M Hidalgo CJ Yeo 2002 An introduction to pancreatic adenocarcinoma genetics, pathology and therapy Cancer Biol Ther 1 607 613
28. I Schwarte-Waldhoff OV Volpert NP Bouck B Sipos SA Hahn S Klein-Scory 2000 Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis Proc Natl Acad Sci USA 97 9624 9629
29. PS Moore S Beghelli G Zamboni A Scarpa 2003 Genetic abnormalities in pancreatic cancer Mol Cancer 2 7
30. CA Staley KR Cleary JL Abbruzzese JE Lee FC Ames CJ Fenoglio 1996 The need for standardized pathologic staging of pancreaticoduodenectomy specimens Pancreas 12 373 380
31. JW Marsh SD Finkelstein AJ Demetris PA Swalsky E Sasatomi A Bandos 2003 Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival Liver Transplant 9 664 671
32. J Momand HH Wu G Dasgupta 2000 MDM2-master regulator of the p53 tumor suppressor protein Gene 242 15 29
33. G Butturini DD Stocken MN Wente H Jeekel JH Klinkenbijl KE Bakkevold 2008 Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials Arch Surg 143 75 83 discussion
34. DD Stocken MW Buchler C Dervenis C Bassi H Jeekel JH Klinkenbijl 2005 Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer Br J Cancer 92 1372 1381
35. T Yatsuoka M Sunamura T Furukawa S Fukushige T Yokoyama H Inoue 2000 Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma Am J Gastroenterol 95 2080 2085
36. EH Mahlamaki M Hoglund L Gorunova R Karhu S Dawiskiba A Andren-Sandberg 1997 Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer Genes Chromosomes Cancer 20 383 391
37. CA Iacobuzio-Donahue MS van der Heijden MR Baumgartner WJ Troup JM Romm K Doheny 2004 Large-scale allelotype of pancreaticobiliary carcinoma provides quantitative estimates of genome-wide allelic loss Cancer Res 64 871 875
38. C Salek L Benesova M Zavoral V Nosek L Kasperova M Ryska 2007 Evaluation of clinical relevance of examining K-ras, p16 and p53 mutations along with allelic losses at 9p and 18q in EUS-guided fine needle aspiration samples of patients with chronic pancreatitis and pancreatic cancer World J Gastroenterol 13 3714 3720
39. M Yamano H Fujii T Takagaki N Kadowaki H Watanabe T Shirai 2000 Genetic progression and divergence in pancreatic carcinoma Am J Pathol 156 2123 2133
40. V Giroux C Malicet M Barthet M Gironella C Archange JC Dagorn 2006 p8 is a new target of gemcitabine in pancreatic cancer cells Clin Cancer Res 12 235 241
41. H Han DJ Bearss LW Browne R Calaluce RB Nagle DD Von Hoff 2002 Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray Cancer Res 62 2890 2896
42. CA Iacobuzio-Donahue A Maitra M Olsen AW Lowe NT van Heek C Rosty 2003 Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays Am J Pathol 162 1151 1162
43. SA Hahn AB Seymour AT Hoque M Schutte LT da Costa MS Redston 1995 Allelotype of pancreatic adenocarcinoma using xenograft enrichment Cancer Res 55 4670 4675
44. LP Lefter M Sunamura T Furukawa K Takeda N Kotobuki M Oshimura 2003 Inserting chromosome 18 into pancreatic cancer cells switches them to a dormant metastatic phenotype Clin Cancer Res 9 5044 5052
45. KW Kinzler B Vogelstein 1998 Landscaping the cancer terrain Science 280 1036 1037
46. M Streit L Riccardi P Velasco LF Brown T Hawighorst P Bornstein 1999 Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis Proc Natl Acad Sci USA 96 14888 14893
47. T Hirama HP Koeffler 1995 Role of the cyclin-dependent kinase inhibitors in the development of cancer Blood 86 841 854
48. M Dong G Ma W Tu KJ Guo YL Tian YT Dong 2005 Clinicopathological significance of p53 and mdm2 protein expression in human pancreatic cancer World J Gastroenterol 11 2162 2165
49. G Bollag F McCormick 1991 Regulators and effectors of ras proteins Annu Rev Cell Biol 7 601 632
50. N Ikeda Y Nakajima M Sho M Adachi CL Huang K Iki 2001 The association of K-ras gene mutation and vascular endothelial growth factor gene expression in pancreatic carcinoma Cancer 92 488 499
51. DH Berger H Chang M Wood L Huang CW Heath T Lehman 1999 Mutational activation of K-ras in nonneoplastic exocrine pancreatic lesions in relation to cigarette smoking status Cancer 85 326 332
52. J Downward 1998 Mechanisms and consequences of activation of protein kinase B/Akt Curr Opin Cell Biol 10 262 267
53. JF Tseng CP Raut JE Lee PW Pisters JN Vauthey EK Abdalla 2004 Pancreaticoduodenectomy with vascular resection: margin status and survival duration J Gastrointest Surg 8 935 949 discussion 49-50
54. RE Schwarz DD Smith 2006 Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database Ann Surg Oncol 13 1189 1200
55. A Strom C Bonal R Ashery-Padan N Hashimoto ML Campos A Trumpp 2007 Unique mechanisms of growth regulation and tumor suppression upon Apc inactivation in the pancreas Development 134 2719 2725
56. B Schniewind S Groth S Sebens Muerkoster B Sipos H Schafer H Kalthoff 2007 Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function Oncogene 26 4850 4862
57. M Schutte RH Hruban J Geradts R Maynard W Hilgers SK Rabindran 1997 Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas Cancer Res 57 3126 3130
58. S Shangary D Qin D McEachern M Liu RS Miller S Qiu 2008 Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition Proc Natl Acad Sci USA 105 3933 3938
59. VA Carroll M Ashcroft 2008 Regulation of angiogenic factors by HDM2 in renal cell carcinoma Cancer Res 68 545 552
60. S Okamura H Arakawa T Tanaka H Nakanishi CC Ng Y Taya 2001 p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis Mol Cell 8 85 94